A randomized double-blind phase 2 study comparing the efficacy, safety, and tolerability of combination antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the treatment of influenza in adults at risk for complications

This is a multicentered, randomized double-blind phase 2 study that will assess the efficacy, safety, and tolerability of combination antivirals (ribavirin, Tamiflu and amantadine) versus the standard treatment (Tamiflu) for the treatment of influenza in an at-risk outpatient population.